UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Ildong presents cancer treatment at US conference
Visitors view Ildong’s research results on anti-cancer drug candidates at t...
by Lee Han-soo
|
2018-04-27 17:12
라인
Will US oncology conference boost Korean biotech shares?
Whether the upcoming annual meeting of the American Society of Clinical Onc...
by Nam Doo-hyun
|
2018-04-27 16:29
라인
‘Sanofi Korea’s Dupixent has low possibility of reimbursement’
Sanofi-Aventis Korea has finally launched its atopic dermatitis therapy Dup...
by Marian Chu
|
2018-04-26 17:01
라인
Why is Medipost enhancing cord blood biz?
Medipost is aggressively pushing to encourage customers to extend their umb...
by So Jae-hyeon
|
2018-04-26 16:44
라인
CJ Healthcare to co-market Dong-A ST’s diabetes treatment
CJ Healthcare said Thursday that it plans to co-market Dong-A ST’s two diab...
by Lee Han-soo
|
2018-04-26 16:01
라인
Guerbet Korea under fire for exploiting monopoly drug
Guerbet Korea, the supplier of contrast media Lipiodol, is being criticized...
by Nam Doo-hyun
|
2018-04-26 15:37
라인
Sanofi to test new diabetic drug in phase-3 study
Sanofi-Aventis Korea said it would start phase-3 clinical trials (SAR439954...
by Lee Hye-seon
|
2018-04-26 14:40
라인
GC Pharma has most patents among large drug suppliers
GC Pharma had the largest number of patents among top-ranking local drugmak...
by Nam Doo-hyun
|
2018-04-26 11:08
라인
Humedix completes P3 trial for osteoarthritis treatment
Humedix, a subsidiary of Huons, said Wednesday that it has completed phase ...
by Lee Han-soo
|
2018-04-25 12:11
라인
Gastric cancer drug Cyramza to get insurance benefit
Eli Lilly’s Cyramza (ingredient: ramucirumab), treating metastatic gastric ...
by Park Gi-taek
|
2018-04-25 11:11
라인
Spectrum to publish trial results of Hanmi's cancer treatment
Spectrum, Hanmi Pharmaceutical’s U.S. partner, said Tuesday that it plans t...
by Lee Han-soo
|
2018-04-24 11:52
라인
Pharma group asks members to join in developing new antibiotics
Korea Pharmaceutical and Bio-Pharma Manufactures Association (KPBMA) said i...
by Lee Han-soo
|
2018-04-24 11:52
라인
3 Korean pipelines listed in 537 new drug candidates in US
Three Korean treatments were included in 537 innovative drug candidates for...
by Nam Doo-hyun
|
2018-04-24 11:21
라인
Insulin Toujeo beats Tresiba in patient number
Novo Nordisk Korea recently boasted that its insulin product Tresiba (ingre...
by Nam Doo-hyun
|
2018-04-23 16:01
라인
Daewoong unveils trial results for anti-ulcer agent
Professor Lee Jong-wook presents the domestic phase 1 clinical trial result...
by Lee Han-soo
|
2018-04-23 11:48
라인
Korean units of GSK, Pfizer send highest dividends to parent firms
Korean units of GlaxoSmithKline (GSK) and Pfizer showed the highest propens...
by Nam Doo-hyun
|
2018-04-20 14:48
라인
Novartis embroiled in another illegal kickback allegation
Novartis, the Switzerland-based multinational pharmaceutical company, is fa...
by Lee Han-soo
|
2018-04-20 14:18
라인
Drugmakers compete to develop liver drugs
Korean pharmaceutical companies are increasingly competing to develop new t...
by So Jae-hyeon
|
2018-04-20 14:18
라인
Huons gets FDA nod for local anesthetics
Huons said Thursday that it has received approval of the company’s abbrevia...
by Lee Han-soo
|
2018-04-19 17:32
라인
Pharma sector embraces work-life balance
Some companies in the pharmaceutical industry are changing their corporate ...
by So Jae-hyeon
|
2018-04-19 14:25
-
이전
81
82
83
84
85
86
87
88
89
90
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top